Important Notice to Long-Term Shareholders of First Solar, Inc. (NSADAQ: FSLR); Insulet Corporation (NASDAQ: PODD); Photronics, Inc. (NASDAQ: PLAB); and Via Transportation, Inc. (NYSE: VIA): Grabar Law Office is Investigating Claims on Your Behalf

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

PHILADELPHIA, July 10, 2026 (GLOBE NEWSWIRE) --

FIRST SOLAR, INC. (NASDAQ: FSLR):

Grabar Law Office is investigating claims on behalf of shareholders of First Solar, Inc. (NASDAQ: FSLR).

WHAT IS THE INVESTIGATION ABOUT? The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased Frist Solar, Inc. (NASDAQ: FSLR) shares prior to February 26, 2025, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. Please visit https://grabarlaw.com/the-latest/fslr-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085.

WHY? As alleged in a recently filed securities fraud class action complaint, Frist Solar, Inc. (NASDAQ: FSLR), through certain of its executives, violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) Defendants had overstated First Solar’s capacity to manage the impact of U.S. tariff policy on the Company’s business; (2) Defendants understated the extent to which its responses to U.S. tariff policy, including the intentional underutilization of production facilities in Malaysia and Vietnam, and attempted relocation of production to the U.S., were likely to negatively impact First Solar’s projected performance in the 2026 fiscal year; and (3) as a result, Defendants’ public statements were materially false and misleading at all relevant times.

WHAT CAN YOU DO NOW? If you purchased Frist Solar, Inc. (NASDAQ: FSLR) shares prior to February 26, 2025, and still hold shares today, you are encouraged to visit https://grabarlaw.com/the-latest/fslr-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. You can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. #FirstSolar $FSLR #FSLR

INSULET CORPORATION (NASDAQ: PODD):

Grabar Law Office is investigating claims on behalf of shareholders of Insulet Corporation (NASDAQ: PODD).

WHAT IS THIS INVESTIGATION ABOUT? The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased Insulet Corporation (NASDAQ: PODD) shares prior to February 21, 2025, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. Please visit https://grabarlaw.com/the-latest/insulet-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. Alternatively, if you purchased Insulet shares between February 21, 2025 and May 26, 2026, you can participate in the class action.

WHY? As alleged in a recently filed federal securities fraud class action complaint, Insulet Corporation (NASDAQ: PODD), through certain of its executives, violated federal securities laws by making false and/or misleading statements and/or failed to disclose that: (i) Insulet’s manufacturing controls and procedures were defective; (ii) the foregoing created a foreseeable heightened risk that one or more Insulet products would be found to be in violation of applicable safety regulations and/or pose a risk of injury; and (iii) as a result, Defendants’ public statements were materially false and misleading at all relevant times.

The truth began to emerge on March 12, 2026, when Insulet disclosed that it had “initiated a voluntary Medical Device Correction for specific lots of Omnipod® 5 Pods after identifying a manufacturing issue through its ongoing product monitoring.” Then, on May 26, 2026, Insulet disclosed the “initat[ion]” of another “voluntary Medical Device Correction” (the “May 2026 MDC”), this time “for specific lots of Omnipod® 5, Omnipod Dash®, and Omnipod® Insulin Management System (Omnipod Eros) Pods due to a manufacturing issue, identified through ongoing product monitoring, that could result in insulin under-delivery.”

WHAT CAN YOU DO NOW? If you purchased Insulet Corporation (NASDAQ: PODD) shares prior to February 21, 2025, and still hold shares today, you are encouraged to visit https://grabarlaw.com/the-latest/insulet-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. You can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. Alternatively, if you purchased Insulet shares between February 21, 2025 and May 26, 2026, you can participate in the class action. #Insulet, #PODD $PODD

PHOTRONICS, INC. (NASDAQ: PLAB):

Grabar Law Office is investigating claims on behalf of shareholders of Photronics, Inc. (NASDAQ: PLAB):

WHAT IS THE INVESTIGATION ABOUT? The investigation concerns whether certain officers and directors of Photronics, Inc. (NASDAQ: PLAB) breached the fiduciary duties they owed to the Company and its shareholders. 

If you purchased Photronics, Inc. (NASDAQ: PLAB) stock before December 10, 2025, and still hold your shares today, you can seek corporate governance reforms, the recovery of damages suffered by the Company, and a court-approved incentive award, all at no cost to you whatsoever. Learn more at https://grabarlaw.com/the-latest/photronics-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call (267) 507-6085.

WHY? A recently filed federal securities class action complaint alleges that Photronics, Inc. (NASDAQ: PLAB) and certain executives repeatedly made materially false or misleading representations that demand for the Company's high-end IC photomask products remained strong, that customer order patterns were robust, and that the Company was well positioned to benefit from increasing demand for advanced semiconductor manufacturing. The complaint alleges that these statements were materially false or misleading because the Company allegedly knew, but failed to disclose, that customer design releases had stalled due to elevated foundry utilization, memory-related cost pressures, and other operational bottlenecks that impaired the Company's growth expectations.

WHAT CAN YOU DO NOW? If you purchased Photronics stock before December 10, 2025, and still hold shares today, please visit https://grabarlaw.com/the-latest/photronics-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call (267) 507-6085. You can seek corporate governance reforms, the recovery of damages suffered by the Company, and a court-approved incentive award, all at no cost to you whatsoever. #PLAB #Photronics $PLAB

VIA TRANSPORTATION, INC. (NYSE: VIA):

Grabar Law Office is investigating claims on behalf of shareholders of Via Transportation Inc. (NYSE: VIA).

WHAT IS THIS INVESTIGATION ABOUT? The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased Via Transportation Inc. (NYSE: VIA) shares on or shortly after the Company’s September 15, 2025 IPO, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.
Please visit https://grabarlaw.com/the-latest/via-transportation-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085 to learn more.

WHY? According to a recently filed federal securities class action lawsuit, Via Transportation Inc. (NYSE: VIA), through certain of its officers, published IPO offering documents were materially false and/or misleading and/or omitted to state other facts necessary to make the statements made not misleading, including that: (i) at the time of the IPO, Via Transportation was adding customers faster than those customers were generating revenue, resulting in a decline in Platform Annual Run-Rate Revenue per customer; and (ii) existing regulatory issues would hinder Via Transportation’s “land and expand” strategy in Germany.

WHAT CAN YOU DO NOW? If you purchased Via Transportation Inc. (NYSE: VIA) shares on or shortly after the Company’s September 15, 2025 IPO, and still hold shares today, you are encouraged to visit https://grabarlaw.com/the-latest/via-transportation-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. You can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. $VIA #VIA #ViaTransportation

Attorney Advertising Disclaimer

Contact:
Joshua H. Grabar, Esq.
Grabar Law Office
One Liberty Place
1650 Market Street, Suite 3600
Philadelphia, PA 19103
Tel:  267-507-6085
Email: jgrabar@grabarlaw.com


Primary Logo

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  245.95
-1.09 (-0.44%)
AAPL  314.73
-1.49 (-0.47%)
AMD  553.27
+6.55 (1.20%)
BAC  59.70
+0.45 (0.77%)
GOOG  353.09
-3.15 (-0.88%)
META  667.70
+36.22 (5.74%)
MSFT  385.62
+1.25 (0.33%)
NVDA  209.58
+6.80 (3.35%)
ORCL  142.90
-0.82 (-0.57%)
TSLA  412.36
+5.81 (1.43%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.